BR0201569A - 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7 - Google Patents

4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7

Info

Publication number
BR0201569A
BR0201569A BR0201569-2A BR0201569A BR0201569A BR 0201569 A BR0201569 A BR 0201569A BR 0201569 A BR0201569 A BR 0201569A BR 0201569 A BR0201569 A BR 0201569A
Authority
BR
Brazil
Prior art keywords
piperizines
pyridyl
receptor agonist
agonist activity
compounds
Prior art date
Application number
BR0201569-2A
Other languages
English (en)
Inventor
Willard Mckowan Welch Jr
Vinod Dipak Parikh
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0201569A publication Critical patent/BR0201569A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"4-(2-PIRIDIL)PIPERIZINAS POSSUINDO UMA ATIVIDADE AGONISTA DO RECEPTOR 5HT7". A presente invenção refere-se a compostos de fórmula I em que R^ 1^, R^ 2^, R^ 3^, X e Y são tal como definidos no relatório descritivo. Estes compostos são agonistas parciais de 5HT7 e são úteis no tratamento de vários distúrbios do sistema nervoso central.
BR0201569-2A 2001-05-02 2002-05-02 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7 BR0201569A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28817801P 2001-05-02 2001-05-02
US28946601P 2001-05-08 2001-05-08

Publications (1)

Publication Number Publication Date
BR0201569A true BR0201569A (pt) 2003-06-10

Family

ID=26964875

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0201569-2A BR0201569A (pt) 2001-05-02 2002-05-02 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7

Country Status (12)

Country Link
US (2) US20030008880A1 (pt)
EP (1) EP1254905B1 (pt)
JP (1) JP2003012648A (pt)
AT (1) ATE256678T1 (pt)
BR (1) BR0201569A (pt)
CA (1) CA2384344A1 (pt)
DE (1) DE60200135T2 (pt)
DK (1) DK1254905T3 (pt)
ES (1) ES2210218T3 (pt)
MX (1) MXPA02004409A (pt)
PT (1) PT1254905E (pt)
TR (1) TR200400027T4 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035753A1 (ja) 2003-10-10 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 機能蛋白質を代替する二重特異性抗体
WO2005035754A1 (ja) 2003-10-14 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 機能蛋白質を代替する二重特異性抗体
AR049478A1 (es) * 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
US20060013874A1 (en) * 2004-07-15 2006-01-19 Solvay Pharmaceuticals B.V. Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one
TW200914020A (en) 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists
US7910588B2 (en) 2007-10-12 2011-03-22 Eli Lilly And Company 5-HT7 receptor antagonists
EP2149373A1 (en) * 2008-08-01 2010-02-03 Laboratorios Del. Dr. Esteve, S.A. 5HT7 receptor ligands and compositions comprising the same
CN106573872B (zh) * 2014-05-19 2021-07-20 东北大学 5-羟色胺受体靶向化合物和方法
DE102018120011B4 (de) 2018-08-16 2022-06-15 Trumpf Laser Und Systemtechnik Gmbh Schweißverfahren zum Verbinden eines transparenten, aluminiumoxidhaltigen ersten Substrats mit einem opaken zweiten Substrat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9612885D0 (en) * 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
FR2761067B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique
GB9710523D0 (en) * 1997-05-23 1997-07-16 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
US7009051B2 (en) 2006-03-07
CA2384344A1 (en) 2002-11-02
JP2003012648A (ja) 2003-01-15
EP1254905B1 (en) 2003-12-17
US20040014769A1 (en) 2004-01-22
US20030008880A1 (en) 2003-01-09
TR200400027T4 (tr) 2004-03-22
PT1254905E (pt) 2004-03-31
MXPA02004409A (es) 2002-11-14
DE60200135D1 (de) 2004-01-29
ATE256678T1 (de) 2004-01-15
DE60200135T2 (de) 2004-06-03
DK1254905T3 (da) 2004-03-29
ES2210218T3 (es) 2004-07-01
EP1254905A1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
DK0675886T3 (da) Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister
DK1864975T3 (da) Nikotinamid-derivater anvendelige som P38-inhibitorer
ATE366724T1 (de) Kondensierte heterocyclische derivate
GB0325956D0 (en) Novel compounds
DE69903992D1 (de) Heterocyclische Carboxamide
EP1423370A4 (en) COMPOUNDS BINDING TO THE NUCLEAR FXR-NR1H4 RECEPTOR
NO20064238L (no) Imidazolinderivater med CB1 agonistlsk aktivitet
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
DE60237528D1 (de) Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
BR0201569A (pt) 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
DE502004007387D1 (de) Triazolverbindungen und ihre therapeutische verwendung
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
ATE383343T1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden
DK1055665T3 (da) 3-(3-hydroxyphenyl)-3-aminopropionamidderivater
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
NO20004075L (no) Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister
DK1409490T3 (da) 2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.